CIMT was found to be higher in patients with subclinical and overt hypothyroidism than in HCs (P = 0.042 and P
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background/aim: The aim of this study is to evaluate the relationship between serum fatty acid binding protein 4 (FABP4) levels andcarotid intima media thickness (CIMT) in patients with hypothyroidism.Materials and methods: Forty subclinical hypothyroidism patients, 40 overt hypothyroidism patients, and 40 healthy controls wereenrolled in the study.
📊
Key Findings & Data:Blood pressure, body mass index, CIMT, fasting blood sugar, creatine, alanine aminotransferase, lipid parameters,insulin, free thyroxine, triiodothyronine, thyroid-stimulating hormone (TSH), thyroid peroxidase antibody (anti-TPO), thyroglobulinantibody (anti-TG), high-sensitivity C-reactive protein (Hs-CRP), and FABP4 levels of all participants were measured.Results: Serum FABP4 levels were significantly higher in patients with subclinical and overt hypothyroidism than healthy controls(HCs) (P = 0.044 and P = 0.014, respectively).
💡
Conclusion & Impact:CIMT was found to be higher in patients with subclinical and overt hypothyroidism than in HCs (P = 0.042 and P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Background/aim: The aim of this study is to evaluate the relationship between serum fatty acid binding protein 4 (FABP4) levels andcarotid intima media thickness (CIMT) in patients with hypothyroidism.Materials and methods: Forty subclinical hypothyroidism patients, 40 overt hypothyroidism patients, and 40 healthy controls wereenrolled in the study. Blood pressure, body mass index, CIMT, fasting blood sugar, creatine, alanine aminotransferase, lipid parameters,insulin, free thyroxine, triiodothyronine, thyroid-stimulating hormone (TSH), thyroid peroxidase antibody (anti-TPO), thyroglobulinantibody (anti-TG), high-sensitivity C-reactive protein (Hs-CRP), and FABP4 levels of all participants were measured.Results: Serum FABP4 levels were significantly higher in patients with subclinical and overt hypothyroidism than healthy controls(HCs) (P = 0.044 and P = 0.014, respectively). There was no significant difference in terms of FABP4 levels between patients withsubclinical and overt hypothyroidism (P = 0.641). Serum TSH levels and serum FABP4 levels were positively correlated (r = 0.201,P = 0.039). CIMT was found to be higher in patients with subclinical and overt hypothyroidism than in HCs (P = 0.042 and P
🔖
Cite This Article
KORKMAZ, H., TAN, M., AYDIN, H., DOĞUÇ, D. K. (2022). FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 5, 1490–1497. https://ajindex.com/articles/610067
Antunes TT, Gagnon A, Bell A, Sorisky A. Thyroid‐stimulating hormone stimulates interleukin‐6 release from 3T3‐L1 adipocytes through a cAMP‐protein kinase A pathway. Obesity Research 2005
13 (12): 2066-2071. doi: 10.1038/oby.2005.256 2. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology & Metabolism 2003
88 (8): 3731-3737. doi: 10.1210/jc.2003-030039 3. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997
53 (3): 278-279. doi: 10.1016/j.metabol.2003.10.003 5. Giannotti G, Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis. Herz 2007
32 (7): 568-572. doi: 10.1007/s00059-007-3073-1 6. Milani AT, Khadem-Ansari MH, Rasmi Y. Effects of thyroidstimulating hormone on adhesion molecules and pro-inflammatory cytokines secretion in human umbilical vein endothelial cells. Research in Pharmaceutical Sciences 2018
13 (6): 546-556. doi: 10.4103/1735-5362.245966 7. Ahn N, Kim HS, Kim K. Exercise training–induced changes in metabolic syndrome parameters, carotid wall thickness, and thyroid function in middle-aged women with subclinical hypothyroidism. Pflugers Archiv-European Journal of Physiology 2019
471 (3): 479-489. doi: 10.1007/s00424-019-02254-7 8. Hak AE, Pols HA, Visser TJ, Drexhage HA et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine 2000
132 (4): 270-278. doi: 10.7326/0003-4819-132-4-200002150-00004 9. Bielecka-Dabrowa A, Godoy B, Suzuki T, Banach M, von Haehling S. Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function. Clinical Research in Cardiology 2019
108 (3): 225-233. doi: 10.1007/s00392-018-1340-1 10. Elbers LP, Squizzato A, Gerdes VEA. Thyroid disorders and hemostasis. Seminars in Thrombosis and Haemostasis 2018